Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial
Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page
- Check5 days agoChange DetectedThe webpage has removed the date '2023-11-18' and added '2025-06-26'.SummaryDifference0.9%
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference4%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check34 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check41 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.